Searchable abstracts of presentations at key conferences in endocrinology

ea0021p361 | Steroids | SFEBES2009

Anti-inflammatory effects of SGRMs: are they dependent on DUSP1?

Joanny Eugenie , Martins Joana , Clark Andrew

Glucocorticoids (GCs) are steroid hormones, products of the hypothalamic–pituitary–adrenal axis. Synthetic GCs, such as dexamethasone, have been widely used in the treatment of inflammatory diseases like rheumatoid arthritis or asthma, but their long-term use causes severe side effects (osteoporosis, diabetes, hypertension, etc). The ligand-bound GC receptor (GR) can activate gene expression via binding to GC response elements (GREs), a mechanism known as transactiva...

ea0015p219 | Pituitary | SFEBES2008

Low dose cabergoline in hyperprolactinaemia is not associated with clinically significant valvular heart disease

Wakil Ammar , Clark Andrew , Atkin Stephen

Introduction: Recent trials suggest that using ergot-derived dopamine agonists such as cabergoline in the treatment of Parkinson’s disease is associated with an increased risk of valvular heart disease. However, the dose of cabergoline used to treat hyperprolactinaemia is considerably less than that used in Parkinson’s disease.Study design: A cross-sectional study; forty four patients, who received cabergoline for at least 6 months, underwent t...

ea0020htc2 | Hot topics: Clinical | ECE2009

Primary hyperparathyroidism (Nationwide cohort study): an increased risk of cancer and decreased survival

Ghosh Sujoy , Collier Andrew , Clark David , Elhadd Tarik , Malik Iqbal

Introduction: The incidence of primary hyperparathyroidism (PHPT) is ~3.5/100 000 per yearThe incidence is on the rise due to increase in ‘routine biochemical testing’Has been thought to be a ‘relatively harmless’ disorder.Some patients tend to undergo surgery, while others are conservatively treated and most followed up for a short period before discharge from follow up.Aims:<l...